Neonatal medicine

Published on 21/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 3 (1 votes)

This article have been viewed 4185 times

Neonatal medicine

The dramatic reduction in neonatal mortality throughout the developed world has resulted from advances in the management of newborn infants together with improvements in maternal health and obstetric care. Neonatal intensive care became increasingly available in the UK from 1975, and it is since that time that the mortality of very low birthweight (VLBW) infants has fallen (Fig. 10.1).

About 8–10% of babies born in the UK are admitted to a neonatal unit for special medical and nursing care, although whenever possible babies are cared for on postnatal wards to avoid separating mothers from their babies. About 1–3% of babies require intensive care.

In the UK, neonatal units are organised as networks, with units providing either:

Modern technology allows even tiny preterm infants to benefit from the full range of intensive care, anaesthesia and surgery. If it is anticipated during pregnancy that the infant is likely to require long-term intensive care or surgery, it is preferable for the transfer to the tertiary centre to be made in utero. When a baby requires transfer postnatally, transport should be by an experienced team of doctors and nurses. Arrangements should also be made for parents to be close to their infant during this stressful time.

Hypoxic-ischaemic encephalopathy

In perinatal asphyxia, gas exchange, either placental or pulmonary, is compromised or ceases altogether, resulting in cardiorespiratory depression. Hypoxia, hypercarbia and metabolic acidosis follow. Compromised cardiac output diminishes tissue perfusion, causing hypoxic-ischaemic injury to the brain and other organs. The neonatal condition is called hypoxic-ischaemic encephalopathy (HIE). It remains an important cause of brain damage, resulting in disability (Fig. 10.2) or death, and its prevention is one of the key aims of modern obstetric care. In developed countries, approximately 0.5–1/1000 liveborn term infants develop HIE and 0.3/1000 have significant neurologic disability. The incidence is higher in developing countries.

Most cases of hypoxic-ischaemic encephalopathy (HIE) follow a significant hypoxic event immediately before or during labour or delivery. These include:

The clinical manifestations start immediately or up to 48 h after asphyxia, and can be graded:

The neuronal damage may be immediate from primary neuronal death or may be delayed from reperfusion injury causing secondary neuronal death. This delay offers the opportunity for neuroprotection with mild hypothermia.

Management

Skilled resuscitation and stabilisation of sick infants will minimise neuronal damage. Infants with HIE may need:

Recent randomised clinical trials have shown that mild hypothermia (cooling to a rectal temperature of 33–34° C for 72 h by wrapping the infant in a cooling blanket) reduces brain damage if started within 6 h of birth.

Prognosis

When HIE is mild, complete recovery can be expected. Infants with moderate HIE who have recovered fully on clinical neurological examination and are feeding normally by 2 weeks of age have an excellent long-term prognosis, but if clinical abnormalities persist beyond that time, full recovery is unlikely. Severe HIE has a mortality of 30–40%, and, of the survivors, over 80% have neurodevelopmental disabilities, particularly cerebral palsy. If magnetic resonance imaging (MRI) at 4–14 days in a term infant shows significant abnormalities (bilateral abnormalities in the basal ganglia and thalamus and lack of myelin in the posterior limb of the internal capsule), there is a very high risk of later cerebral palsy (Fig. 10.3).

Although hypoxic-ischaemic injury usually occurs antenatally or during labour or delivery, it may occur postnatally or be caused by a neonatal condition (e.g. inborn error of metabolism or kernicterus). The diagnosis ‘birth asphyxia’ has potentially serious medicolegal implications; it has been recommended that infants who have the clinical features of HIE should only be considered to have birth asphyxia if there is:

Birth injuries

Infants may be injured at birth, particularly if they are malpositioned or too large for the pelvic outlet. Injuries may also occur during manual manoeuvres, from forceps blades or at Ventouse deliveries. Fortunately, now that Caesarean section is available in every maternity unit, heroic attempts to achieve a vaginal delivery with resultant severe injuries to the infant have become extremely rare.

Soft tissue injuries

These include:

• Caput succedaneum (Fig. 10.4) – bruising and oedema of the presenting part extending beyond the margins of the skull bones; resolves in a few days

• Cephalhaematoma (Figs 10.4, 10.5) – haematoma from bleeding below the periosteum, confined within the margins of the skull sutures. It usually involves the parietal bone. The centre of the haematoma feels soft. It resolves over several weeks

• Chignon (Fig. 10.6) – oedema and bruising from Ventouse delivery

• Bruising to the face after a face presentation and to the genitalia and buttocks after breech delivery. Preterm infants bruise readily from even mild trauma

• Abrasions to the skin from scalp electrodes applied during labour or from accidental scalpel incision at Caesarean section

• Forceps marks to face from pressure of blades – transient

• Subaponeurotic haemorrhage (Fig. 10.4) (very uncommon) – diffuse, boggy swelling of scalp on examination, blood loss may be severe and lead to hypovolaemic shock and coagulopathy.

Nerve palsies

Brachial nerve palsy results from traction to the brachial plexus nerve roots. They may occur at breech deliveries or with shoulder dystocia. Upper nerve root (C5 and C6) injury results in an Erb palsy (Fig. 10.7). It may be accompanied by phrenic nerve palsy causing an elevated diaphragm. Most palsies resolve completely, but should be referred to an orthopaedic or plastic surgeon if not resolved by 2–3 months. Most recover by 2 years. A facial nerve palsy may result from compression of the facial nerve against the mother’s ischial spine. It is unilateral, and there is facial weakness on crying but the eye remains open. It is usually transient, but methylcellulose drops may be needed for the eye. Rarely, nerve palsies may be from damage to the cervical spine, when there is lack of movement below the level of the lesion.

Stabilising the preterm or sick infant

Preterm infants of <34 weeks’ gestation and newborn infants who become seriously ill require their condition to be stabilised and monitored (Fig. 10.8). Many of them will need respiratory and circulatory support.

Stabilising preterm or sick infants

Venous and arterial lines

The preterm infant

The appearance, the likely clinical course, chances of survival and long-term prognosis depend on the gestational age at birth. The appearance and maturational changes of very preterm infants are described in Table 10.1 and the importance of parental involvement shown in Figures 10.10a and b. The external appearance and neurological findings can be scored to provide an estimate of an infant’s gestational age (see Appendix).

The rate and severity of problems associated with prematurity decline markedly with increasing gestation. Infants born at 23–26 weeks’ gestation encounter many problems (Box 10.1), require many weeks of intensive and special care in hospital and have a high overall mortality. With modern intensive care, the prognosis is excellent after 32 weeks’ gestational age. The severity of an infant’s respiratory disease and of any episodes of infection largely determine the neonatal course and outcome.

Respiratory distress syndrome

In respiratory distress syndrome (RDS), (also called hyaline membrane disease), there is a deficiency of surfactant, which lowers surface tension. Surfactant is a mixture of phospholipids and proteins excreted by the type II pneumocytes of the alveolar epithelium. Surfactant deficiency leads to widespread alveolar collapse and inadequate gas exchange. The more preterm the infant, the higher the incidence of RDS; it is common in infants born before 28 weeks’ gestation and tends to be more severe in boys than girls. Surfactant deficiency is rare at term but may occur in infants of diabetic mothers. The term hyaline membrane disease derives from a proteinaceous exudate seen in the airways on histology. Glucocorticoids, given antenatally to the mother, stimulate fetal surfactant production and are given if preterm delivery is anticipated (see Ch. 9.)

The development of surfactant therapy has been a major advance. The preparations are natural, derived from extracts of calf or pig lung. They are instilled directly into the lung via a tracheal tube. Multinational placebo-controlled trials show that surfactant treatment reduces mortality from RDS by about 40%, without increasing the morbidity rate (Fig. 10.11).

At delivery or within 4 h of birth, babies with RDS develop clinical signs of:

The characteristic chest X-ray appearance is shown in Figure 10.12. Treatment with raised ambient oxygen is required, which may need to be supplemented with continuous positive airway pressure (delivered via nasal cannulae) or artificial ventilation via a tracheal tube. The ventilatory requirements need to be adjusted according to the infant’s oxygenation (which is measured continuously), chest wall movements and blood gas analyses. Mechanical ventilation (with intermittent positive pressure ventilation or high-frequency oscillation) may be required. High-flow humidified oxygen therapy, via nasal cannulae, may be used to wean babies from added oxygen therapy.

The preterm infant: maturational changes in appearance and development

Table 10.1

The preterm infant compared with the term infant

Gestation 23–27 weeks Term (37–42 weeks)
Birthweight (50th centile) At 24 weeks – male 700 g, female 620 g At 40 weeks – male 3.55 kg, female 3.4 kg
Skin Very thin (Fig. 10.9a) Thick skin (Fig. 10.9b)
  Dark red colour all over body Pale pink colour
Ears Pinna soft, no recoil Pinna firm, cartilage to edge, immediate recoil
Breast tissue No breast tissue palpable One or both nodules >1 cm
Genitalia Male – scrotum smooth, no testes in scrotum Male – scrotum has rugae, testes in scrotum
  Female – prominent clitoris, labia majora widely separated, labia minora protruding Female – labia minora and clitoris covered
Breathing Needs respiratory support. Apnoea common Rarely needs respiratory support. Apnoea rare
Sucking and swallowing No coordinated sucking Coordinated (from 34–35 weeks)
Feeding Usually needs TPN (total parenteral nutrition), then tube feeding Cries when hungry. Feeds on demand
Cry Faint Loud
Vision, interaction Eyelids may be fused. Infrequent eye movements. Not available for interaction Makes eye contact, alert wakefulness
Hearing Startles to loud noise Responds to sound
Posture Limbs extended, jerky movements Flexed posture, smooth movements

Pneumothorax

In respiratory distress syndrome, air from the overdistended alveoli may track into the interstitium, resulting in pulmonary interstitial emphysema (PIE). In up to 10% of infants ventilated for RDS, air leaks into the pleural cavity and causes a pneumothorax (Fig. 10.13). When this occurs, the infant’s oxygen requirement usually increases, and the breath sounds and chest movement on the affected side are reduced, although this can be difficult to detect clinically. A pneumothorax may be demonstrated by transillumination with a bright fibreoptic light source applied to the chest wall. A tension pneumothorax is treated by inserting a chest drain. In order to try and prevent pneumothoraces, infants are ventilated with the lowest pressures that provide adequate chest movement and satisfactory blood gases.

Apnoea and bradycardia and desaturation

Episodes of apnoea and bradycardia and desaturation are common in very low birthweight infants until they reach about 32 weeks’ gestational age. Bradycardia may occur either when an infant stops breathing for over 20–30 s or when breathing continues but against a closed glottis. An underlying cause (hypoxia, infection, anaemia, electrolyte disturbance, hypoglycaemia, seizures, heart failure or aspiration due to gastro-oesophageal reflux) needs to be excluded, but in many instances, the cause is immaturity of central respiratory control. Breathing will usually start again after gentle physical stimulation. Treatment with the respiratory stimulant caffeine often helps. Continuous positive airways pressure (CPAP) may be necessary if apnoeic episodes are frequent.

Temperature control

Hypothermia causes increased energy consumption and may result in hypoxia and hypoglycaemia, failure to gain weight and increased mortality. Preterm infants are particularly vulnerable to hypothermia, as:

There is a neutral temperature range in which an infant’s energy consumption is at a minimum level. In the very immature baby, this neutral temperature is highest during the first few days of life and subsequently declines. The temperature of these small babies is maintained using incubators (Fig. 10.14) or initially with overhead radiant heaters. Incubators also allow ambient humidity to be provided, which reduces transepidermal heat loss.

Patent ductus arteriosus

The ductus arteriosus remains patent in many preterm infants. Shunting of blood across the ductus, from the left to the right side of the circulation, is most common in infants with RDS. It may produce no symptoms or it may cause apnoea and bradycardia, increased oxygen requirement and difficulty in weaning the infant from artificial ventilation. The pulses are ‘bounding’ from an increased pulse pressure, the precordial impulse becomes prominent and a systolic murmur may be audible. With increasing circulatory overload, signs of heart failure may develop. More accurate assessment of the infant’s circulation can be obtained on echocardiography. If the infant is symptomatic, pharmacological closure with a prostaglandin synthetase inhibitor, indometacin or ibuprofen, is used. If these measures fail to close a symptomatic duct, surgical ligation will be required.

Nutrition

Preterm infants have a high nutritional requirement because of their rapid growth. Preterm infants at 28 weeks’ gestation double their birthweight in 6 weeks and treble it in 12 weeks, whereas term babies double their weight in only 4.5 months and treble it in a year.

Infants of 35–36 weeks’ gestational age are mature enough to suck and swallow milk. Less mature infants will need to be fed via an oro- or nasogastric tube. Even in very preterm infants, enteral feeds, preferably breast milk, are introduced as soon as possible. In these infants, breast milk needs to be supplemented with phosphate and may need supplementation with protein and calories (in breast milk fortifier) and calcium. In some neonatal units, extremely preterm infants are initially fed on donor breast milk if maternal breast milk is not available. If formula feeding is required, special infant formulas are available which are designed to meet the increased nutritional requirements of preterm infants but, in contrast to breast milk, do not provide protection against infection or other benefits of breast milk. In the very immature or sick infant, parenteral nutrition is often required. This is usually given through a central venous catheter, inserted peripherally (PICC lines, peripherally inserted central catheters), paying strict attention to aseptic technique both during insertion and when fluids are changed. However, PICC lines carry a significant risk of septicaemia; other risks include thrombosis of a major vein. For this reason, parenteral nutrition may sometimes be given via a peripheral vein, but extravasation may cause skin damage with scarring. Because of the significant risk of septicaemia from parenteral nutrition and the increased risk of necrotising enterocolitis with cow’s milk based formula, mothers should be encouraged and supported to provide breast milk.

Poor bone mineralisation (osteopenia of prematurity) was previously common but is prevented by provision of adequate phosphate, calcium and vitamin D. Because iron is mostly transferred to the fetus during the last trimester, preterm babies have low iron stores and are at a risk of iron deficiency. This is in addition to loss of blood from sampling and an inadequate erythropoietin response. Iron supplements are started at several weeks of age and continued after discharge home.

Preterm brain injury

Haemorrhages in the brain occur in 25% of very low birthweight infants and are easily recognised on cranial ultrasound scans (Fig. 10.15a). Typically, they occur in the germinal matrix above the caudate nucleus, which contains a fragile network of blood vessels. Most haemorrhages occur within the first 72 h of life. They are more common following perinatal asphyxia and in infants with severe respiratory distress syndrome. Pneumothorax is a significant risk factor. Small haemorrhages confined to the germinal matrix do not increase the risk of cerebral palsy. Haemorrhage may occur in the ventricles. The most severe haemorrhage is unilateral haemorrhagic infarction involving the parenchyma of the brain; this usually results in hemiplegia (Fig. 10.15b).

A large intraventricular haemorrhage may impair the drainage and reabsorption of cerebrospinal fluid (CSF), thus allowing CSF to build up under pressure. This dilatation (Fig. 10.15c) may resolve spontaneously or progress to hydrocephalus, which may cause the cranial sutures to separate, the head circumference to increase rapidly and the anterior fontanelle to become tense. A ventriculoperitoneal shunt may be required, but initially symptomatic relief may be provided by removal of CSF by lumbar puncture or ventricular tap. About half of infants with progressive post-haemorrhagic ventricular dilatation have cerebral palsy, a higher proportion if parenchymal infarction is also present.

Periventricular white matter brain injury may occur following ischaemia or inflammation and may occur in the absence of haemorrhage. It is more difficult to detect by cranial ultrasound. Initially there may be an echodense area or ‘flare’ within the brain parenchyma. This may resolve within a week (in which case the risk of cerebral palsy is not increased), but if cystic lesions become visible on ultrasound 2–4 weeks later, there is definite loss of white matter. Bilateral multiple cysts, called periventricular leukomalacia (PVL), have an 80–90% risk of spastic diplegia, often with cognitive impairment, if posteriorly sited (Fig. 10.15d).

Both intraventricular haemorrhage and periventricular leukomalacia may occur in the absence of abnormal clinical signs.

Necrotising enterocolitis

Necrotising enterocolitis is a serious illness mainly affecting preterm infants in the first few weeks of life. It is associated with bacterial invasion of ischaemic bowel wall. Preterm infants fed cow’s milk formula are more likely to develop this condition than if they are fed only breast milk. The infant stops tolerating feeds, milk is aspirated from the stomach and there may be vomiting, which may be bile-stained. The abdomen becomes distended (Fig. 10.16a) and the stool sometimes contains fresh blood. The infant may rapidly become shocked and require artificial ventilation because of abdominal distension and pain. The characteristic X-ray features are distended loops of bowel and thickening of the bowel wall with intramural gas, and there may be gas in the portal tract (Fig. 10.16b). The disease may progress to bowel perforation, which can be detected by X-ray or by transillumination of the abdomen.

Treatment is to stop oral feeding and give broad-spectrum antibiotics to cover both aerobic and anaerobic organisms. Parenteral nutrition is always needed and artificial ventilation and circulatory support are often needed. Surgery is performed for bowel perforation. The disease has significant morbidity and a mortality of about 20%. Long-term sequelae include the development of strictures and malabsorption if extensive bowel resection has been necessary.

Retinopathy of prematurity

Retinopathy of prematurity (ROP) affects developing blood vessels at the junction of the vascular and non-vascularised retina. There is vascular proliferation which may progress to retinal detachment, fibrosis and blindness. It was initially recognised that the risk is increased by uncontrolled use of high concentrations of oxygen. Now, even with careful monitoring of the infant’s oxygenation, retinopathy of prematurity is still found in about 35% of all very low birthweight infants. As laser therapy reduces visual impairment, the eyes of susceptible preterm infants (<1500 g birthweight or <32 weeks’ gestation) are screened every week by an ophthalmologist. Severe bilateral visual impairment occurs in about 1% of very low birthweight infants, mostly in infants of <28 weeks’ gestation.

Bronchopulmonary dysplasia

Infants who still have an oxygen requirement at a post-menstrual age of 36 weeks are described as having bronchopulmonary dysplasia (BPD) or chronic lung disease. The lung damage comes from pressure and volume trauma from artificial ventilation, oxygen toxicity and infection. The chest X-ray characteristically shows widespread areas of opacification, sometimes with cystic changes (Fig. 10.17). Some infants need prolonged artificial ventilation, but most are weaned onto continuous positive airways pressure (CPAP) followed by additional ambient oxygen, sometimes over several months. Corticosteroid therapy may facilitate earlier weaning from the ventilator and often reduces the infant’s oxygen requirements in the short term, but concern about increased risk of abnormal neurodevelopment including cerebral palsy limits use to those at highest risk and only short courses are given. Some babies go home while still receiving additional oxygen. A few infants with severe disease may die of intercurrent infection or pulmonary hypertension. Subsequent pertussis and RSV (respiratory syncytial virus) infection may cause respiratory failure necessitating intensive care.

Problems following discharge

To prevent anaemia of prematurity, additional iron as supplementation or in preterm formula is given until 6 months corrected age, when iron becomes available from solid foods. Multivitamins are also recommended. The standard immunisations should be given.

Medical problems include increased risk of:

Readmission to hospital during the first year of life is increased approximately four-fold – mainly for respiratory disorders and surgical repair of inguinal hernias.

About 5–10% of very low birthweight infants develop cerebral palsy, but the most common impairments are learning difficulties. The prevalence of cognitive impairment and of other associated difficulties increases with decreasing gestational age at birth, and is greatest if born at very early gestational age (<26 weeks’ gestation) (Fig. 10.18a,b). It becomes increasingly evident when the individual child is compared to their peers at nursery or school. In addition, children may have difficulties with:

A small proportion also have hearing impairment, with 1–2% requiring amplification, or visual impairment, with 1% blind in both eyes. A greater proportion have refraction errors and squints and therefore require glasses.

Jaundice

Over 50% of all newborn infants become visibly jaundiced. This is because:

• there is marked physiological release of haemoglobin from the breakdown of red cells because of the high Hb concentration at birth (Fig. 10.19)

• the red cell life span of newborn infants (70 days) is markedly shorter than that of adults (120 days)

• hepatic bilirubin metabolism is less efficient in the first few days of life.

Neonatal jaundice is important as:

Kernicterus

This is the encephalopathy resulting from the deposition of unconjugated bilirubin in the basal ganglia and brainstem nuclei (Fig. 10.20). It may occur when the level of unconjugated bilirubin exceeds the albumin-binding capacity of bilirubin of the blood. As this free bilirubin is fat-soluble, it can cross the blood–brain barrier. The neurotoxic effects vary in severity from transient disturbance to severe damage and death. Acute manifestations are lethargy and poor feeding. In severe cases, there is irritability, increased muscle tone causing the baby to lie with an arched back (opisthotonos), seizures and coma. Infants who survive may develop choreoathetoid cerebral palsy (due to damage to the basal ganglia), learning difficulties and sensorineural deafness. Kernicterus used to be an important cause of brain damage in infants with severe rhesus haemolytic disease, but has become rare since the introduction of prophylactic anti-D immunoglobulin for rhesus-negative mothers. However, a few cases continue to occur, especially in slightly preterm infants (35–37 weeks), which has led NICE to issue guidelines on the management of neonatal jaundice.

Clinical evaluation

Babies become clinically jaundiced when the bilirubin level reaches about 80 µmol/L. Management varies according to the infant’s gestational age, age at onset, bilirubin level and rate of rise, and the overall clinical condition.

Age at onset

The age of onset is a useful guide to the likely cause of the jaundice (Table 10.2).

Table 10.2

Causes of neonatal jaundice

Jaundice starting at <24 h of age Haemolytic disorders:
 Rhesus incompatibility
 ABO incompatibility
 G6PD deficiency
 Spherocytosis, pyruvate kinase deficiency
Congenital infection
Jaundice at 24 h to 2 weeks of age Physiological jaundice
Breast milk jaundice
Infection, e.g. urinary tract infection
Haemolysis, e.g. G6PD deficiency, ABO incompatibility
Bruising
Polycythaemia
Crigler–Najjar syndrome
Jaundice at >2 weeks of age Unconjugated:
 Physiological or breast milk jaundice
 Infection (particularly urinary tract)
 Hypothyroidism
 Haemolytic anaemia, e.g. G6PD deficiency
 High gastrointestinal obstruction, e.g. pyloric stenosis
Conjugated (>25 µmol/L):
 Bile duct obstruction
 Neonatal hepatitis

image

Jaundice <24 h of age

Jaundice starting within 24 h of birth usually results from haemolysis. This is particularly important to identify as the bilirubin is unconjugated and can rise very rapidly and reach extremely high levels.

Haemolytic disorders

Rhesus haemolytic disease – Affected infants are usually identified antenatally and monitored and treated if necessary (see Ch. 9). The birth of a severely affected infant, with anaemia, hydrops and hepatosplenomegaly with rapidly developing severe jaundice, has become rare. Antibodies may develop to rhesus antigens other than D and to the Kell and Duffy blood groups, but haemolysis is usually less severe.

ABO incompatibility – This is now more common than rhesus haemolytic disease. Most ABO antibodies are IgM and do not cross the placenta, but some group O women have an IgG anti-A-haemolysin in the blood which can cross the placenta and haemolyse the red cells of a group A infant. Occasionally, group B infants are affected by anti-B haemolysins. Haemolysis can cause severe jaundice but it is usually less severe than in rhesus disease. The infant’s haemoglobin level is usually normal or only slightly reduced and, in contrast to rhesus disease, hepatosplenomegaly is absent. The direct antibody test (Coombs’ test), which demonstrates antibody on the surface of red cells, is positive. The jaundice usually peaks in the first 12–72 h.

G6PD deficiency (see Ch. 22) – Mainly in people originating in the Mediterranean, Middle-East and Far East or in African-Americans. Mainly affects male infants, but some females develop significant jaundice. Parents of affected infants should be given a list of drugs to be avoided, as they may precipitate haemolysis.

Spherocytosis – This is considerably less common than G6PD deficiency (see Ch. 22). There is often, but not always, a family history. The disorder can be identified by recognising spherocytes on the blood film.

Jaundice at 2 days to 2 weeks of age

Management

Poor milk intake and dehydration will exacerbate jaundice and should be corrected, but studies have failed to show that routinely supplementing breast-fed infants with water or dextrose solution reduces jaundice. Phototherapy is the most widely used therapy, with exchange transfusion for severe cases.

Phototherapy

Light (wavelength 450 nm) from the blue–green band of the visible spectrum converts unconjugated bilirubin into a harmless water-soluble pigment excreted predominantly in the urine. It is delivered with an overhead light source placed the optimal distance above the infant to achieve high irradiance. Although no long-term sequelae of phototherapy from overhead light have been reported, it is disruptive to normal nursing of the infant and should not be used indiscriminately. The infant’s eyes are covered, as bright light is uncomfortable. Phototherapy can result in temperature instability as the infant is undressed, a macular rash and bronze discoloration of the skin if the jaundice is conjugated.

Continuous multiple (‘intensive’) phototherapy is given if the bilirubin is rising rapidly or has reached a high level.

Exchange transfusion

Exchange transfusion is required if the bilirubin rises to levels which are considered potentially dangerous. Blood is removed from the baby in small aliquots, (usually from an arterial line or the umbilical vein) and replaced with donor blood (via peripheral or umbilical vein). Twice the infant’s blood volume (2 × 80 ml/kg) is exchanged. Donor blood should be as fresh as possible and screened to exclude CMV, hepatitis B and C and HIV infection. The procedure does carry some risk of morbidity and mortality.

Phototherapy has been very successful in reducing the need for exchange transfusion. In infants with rhesus haemolytic disease or ABO incompatibility unresponsive to intensive phototherapy, intravenous immunoglobulin reduces the need for exchange transfusion.

There is no bilirubin level known to be safe or which will definitely cause kernicterus. In rhesus haemolytic disease, it was found that kernicterus could be prevented if the bilirubin was kept below 340 µmol/L (20 mg/dl). As there is no consensus among paediatricians in the UK on the bilirubin levels for phototherapy and exchange transfusion, guidelines have been published by NICE to ensure uniform practice.

Jaundice at >2 weeks of age

Jaundice in babies more than 2 weeks old (3 weeks if preterm), is called persistent or prolonged neonatal jaundice. The key feature is that it may be caused by biliary atresia, and it is important to diagnose biliary atresia promptly, as delay in surgical treatment adversely affects outcome (see Ch. 20 for further details).

However, in most infants with persistent neonatal jaundice, the hyperbilirubinaemia is unconjugated, but this needs to be confirmed on laboratory testing.

In prolonged unconjugated hyperbilirubinaemia:

Conjugated hyperbilirubinaemia (>25 µmol/L) is suggested by the baby passing dark urine and unpigmented pale stools. Hepatomegaly and poor weight gain are other clinical signs that may be present. Its causes include neonatal hepatitis syndrome and biliary atresia, with improved prognosis of biliary atresia with early diagnosis (see Ch. 20 for further details).

Respiratory distress in term infants

Newborn infants with respiratory problems develop the following signs of respiratory distress:

The causes in term infants are listed in Table 10.3.

Table 10.3

Causes of respiratory distress in term infants

Pulmonary  
 Common Transient tachypnoea of the newborn
 Less common Meconium aspiration
Pneumonia
Respiratory distress syndrome
Pneumothorax
Persistent pulmonary hypertension of the newborn
Milk aspiration
 Rare Diaphragmatic hernia
Tracheo-oesophageal fistula (TOF)
Pulmonary hypoplasia
Airways obstruction, e.g. choanal atresia
Pulmonary haemorrhage
Non-pulmonary  
  Congenital heart disease
  Intracranial birth trauma/encephalopathy
  Severe anaemia
  Metabolic acidosis

image

Affected infants should be admitted to the neonatal unit for monitoring of heart and respiratory rates, oxygenation and circulation. A chest X-ray will be required to help identify the cause, especially those causes which may need immediate treatment, e.g. pneumothorax or diaphragmatic hernia. Additional ambient oxygen, mechanical ventilation and circulatory support are given as required.

Meconium aspiration

Meconium is passed before birth by 8–20% of babies. It is rarely passed by preterm infants, and occurs increasingly the greater the gestational age, affecting 20–25% of deliveries by 42 weeks. It may be passed in response to fetal hypoxia. At birth these infants may inhale thick meconium. Asphyxiated infants may start gasping and aspirate meconium before delivery. Meconium is a lung irritant and results in both mechanical obstruction and a chemical pneumonitis, as well as predisposing to infection. In meconium aspiration the lungs are over-inflated, accompanied by patches of collapse and consolidation. There is a high incidence of air leak, leading to pneumothorax and pneumomediastinum. Artificial ventilation is often required. Infants with meconium aspiration may develop persistent pulmonary hypertension of the newborn which may make it difficult to achieve adequate oxygenation despite high pressure ventilation (see below for management). Severe meconium aspiration is associated with significant morbidity and mortality.

Persistent pulmonary hypertension of the newborn

This life-threatening condition is usually associated with birth asphyxia, meconium aspiration, septicaemia or respiratory distress syndrome. It sometimes occurs as a primary disorder. As a result of the high pulmonary vascular resistance, there is right-to-left shunting within the lungs and at atrial and ductal levels. Cyanosis occurs soon after birth. Heart murmurs and signs of heart failure are often absent. A chest X-ray shows that the heart is of normal size and there may be pulmonary oligaemia. An urgent echocardiogram is required to establish that the child does not have congenital heart disease.

Most infants require mechanical ventilation and circulatory support in order to achieve adequate oxygenation. Inhaled nitric oxide, a potent vasodilator, is often beneficial. Another vasodilator, sildenafil (Viagra), has been introduced more recently. High-frequency or oscillatory ventilation is sometimes helpful. Extracorporeal membrane oxygenation (ECMO), where the infant is placed on heart and lung bypass for several days, is indicated for severe but reversible cases, but is only performed in a few specialist centres.

Diaphragmatic hernia

This occurs in about 1 in 4000 births. Many are now diagnosed on antenatal ultrasound screening. In the newborn period, it usually presents with failure to respond to resuscitation or as respiratory distress. In most cases, there is a left-sided herniation of abdominal contents through the posterolateral foramen of the diaphragm. The apex beat and heart sounds will then be displaced to the right side of the chest, with poor air entry in the left chest. Vigorous resuscitation may cause a pneumothorax in the normal lung, thereby aggravating the situation. The diagnosis is confirmed by X-ray of the chest and abdomen (Fig. 10.21). Once the diagnosis is suspected, a large nasogastric tube is passed and suction is applied to prevent distension of the intrathoracic bowel. After stabilisation, the diaphragmatic hernia is repaired surgically, but in most infants with this condition the main problem is pulmonary hypoplasia – where compression by the herniated viscera throughout pregnancy has prevented development of the lung in the fetus. If the lungs are hypoplastic, mortality is high.

Other causes

Other causes of respiratory distress are listed in Table 10.3. When due to heart failure, abnormal heart sounds and/or heart murmurs may be present on auscultation. An enlarged liver from venous congestion is a helpful sign. The femoral arteries must be palpated in all infants with respiratory distress, as coarctation of the aorta and interrupted aortic arch are important causes of heart failure in newborn infants.

Infection

The time of highest risk in childhood for acquiring a serious invasive bacterial infection is the neonatal period. Infections fall into two broad categories, early- and late-onset sepsis.

Early-onset infection

In early-onset sepsis (<48 h after birth), bacteria have ascended from the birth canal and invaded the amniotic fluid. The fetus is secondarily infected because the fetal lungs are in direct contact with infected amniotic fluid. These infants have pneumonia and secondary bacteraemia/septicaemia. In contrast, congenital viral infections and early-onset infection with Listeria monocytogenes, fetal infection is acquired via the placenta following maternal infection.

The risk of early-onset infection is increased if there has been prolonged or premature rupture of the amniotic membranes, and when chorioamnionitis is clinically evident such as when the mother has fever during labour. Presentation is with respiratory distress, apnoea and temperature instability (Box 10.2). A chest X-ray is performed, together with a septic screen. A full blood count is performed to detect neutropenia, as well as blood cultures. An acute-phase reactant (C-reactive protein) is helpful but takes 12–24 h to rise, so one normal result does not exclude infection, but two consecutive normal values are strong evidence against infection. Antibiotics are started immediately without waiting for culture results. Intravenous antibiotics are given to cover group B streptococci, Listeria monocytogenes and other Gram-positive organisms (usually benzylpenicillin or amoxicillin), combined with cover for Gram-negative organisms (usually an aminoglycoside such as gentamicin). If cultures and CRP are negative and the infant has recovered clinically, antibiotics can be stopped after 48 h. If the blood culture is positive or if there are any neurological signs, CSF must be examined and cultured.

Late-onset infection

In late-onset infection (>48 h after birth), the source of infection is often the infant’s environment. The presentation is usually non-specific (Box 10.2). Nosocomially acquired infections are an inherent risk in a neonatal unit, and all staff must adhere strictly to effective hand hygiene measures to prevent cross-infection. In neonatal intensive care, the main sources of infection are indwelling central venous catheters for parenteral nutrition, invasive procedures which break the protective barrier of the skin, and tracheal tubes. Coagulase-negative staphylococcus (Staphylococcus epidermidis) is the most common pathogen, but the range of organisms is broad, and includes Gram-positive bacteria (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative bacteria (Escherichia coli and Pseudomonas, Klebsiella and Serratia species). Initial therapy (e.g. with flucloxacillin and gentamicin) is aimed to cover most staphylococci and Gram-negative bacilli. If the organism is resistant to these antibiotics or the infant’s condition does not improve, specific antibiotics (e.g. vancomycin for coagulase-negative staphylococci or enterococci) or broad-spectrum antibiotics (e.g. meropenem) may be indicated. Use of prolonged or broad-spectrum antibiotics predisposes to invasive fungal infections (e.g. Candida albicans) in premature babies. Serial measurements of an acute-phase reactant (CRP) are useful to monitor response to therapy.

Neonatal meningitis, although uncommon, has a mortality of 20–50%, with one-third of survivors having serious sequelae. Presentation is non-specific (Box 10.2); a bulging fontanelle and hyperextension of neck and back (opisthotonos) are late signs and rarely seen in newborn infants. If meningitis is thought likely, ampicillin or penicillin and a third-generation cephalosporin (e.g. cefotaxime, which has CSF penetration) are given. Complications include cerebral abscess, ventriculitis, hydrocephalus, hearing loss and neurodevelopmental impairment.

Some specific infections

Group B streptococcal infection

Around 10–30% of pregnant women have faecal or vaginal carriage of group B streptococci. The organism causes early- and late-onset sepsis. In early-onset sepsis, the newborn baby has respiratory distress and pneumonia. In the UK, approximately 0.5–1 in 1000 babies have early-onset infection; most have pneumonia only, but it may cause septicaemia and meningitis. The severity of the neonatal presentation depends on the duration of the infection in utero. Mortality in babies with positive blood or CSF cultures is up to 10%.

Up to half of infants born to mothers who carry group B streptococcus are colonised on their mucous membranes or skin. Some of these babies develop late-onset disease, up to 3 months of age. It usually presents with meningitis, or occasionally with focal infection (e.g. osteomyelitis or septic arthritis).

In colonised mothers, risk factors for infection are preterm, prolonged rupture of membranes, maternal fever during labour (>38° C), maternal chorioamnionitis or previously infected infant. Prophylactic intrapartum antibiotics given intravenously to the mother can prevent group B streptococcus infection in the newborn baby. There are two approaches to the use of intrapartum antibiotics – universal screening at 35–38 weeks to identify mothers who carry the organism (as practiced in the USA and Australia) and a risk-based approach, in which mothers with risk factors for infection are offered antibiotics (as in the UK).

Conjunctivitis

Sticky eyes are common in the neonatal period, starting on the 3rd or 4th day of life. Cleaning with saline or water is all that is required and the condition resolves spontaneously. A more troublesome discharge with redness of the eye may be due to staphylococcal or streptococcal infection and can be treated with a topical antibiotic eye ointment, e.g. neomycin.

Purulent discharge with conjunctival injection and swelling of the eyelids within the first 48 h of life may be due to gonococcal infection. The discharge should be Gram-stained urgently, as well as cultured, and treatment started immediately, as permanent loss of vision can occur. In countries such as the UK and the USA where penicillin resistance is a problem, a third-generation cephalosporin is given intravenously. The eye needs to be cleansed frequently.

Chlamydia trachomatis eye infection usually presents with a purulent discharge, together with swelling of the eyelids (Fig. 10.22), at 1–2 weeks of age, but may also present shortly after birth. The organism can be identified with immunofluorescent staining. Treatment is with oral erythromycin for 2 weeks. The mother and partner also need to be checked and treated.

Herpes simplex virus (HSV) infections

Neonatal HSV infection is uncommon, occurring in 1 in 3000 to 1 in 20 000 live births. HSV infection is usually transmitted during passage through an infected birth canal or occasionally by ascending infection. The risk to an infant born to a mother with a primary genital infection is high, about 40%, while the risk from recurrent maternal infection is less than 3%. In most infants who develop HSV infection, the condition is unexpected as the mother does not know that she is infected (asymptomatic or non-specific illness).

Infection is more common in preterm infants. Presentation is at any time up to 4 weeks of age, with localised herpetic lesions on the skin or eye, or with encephalitis or disseminated disease. Mortality due to localised disease is low, but, even with aciclovir treatment, disseminated disease has a high mortality with considerable morbidity after encephalitis. If the mother is recognised as having primary disease or develops genital herpetic lesions at the time of delivery, elective Caesarean section is indicated. Women with a history of recurrent genital infection can be delivered vaginally as the risk of neonatal infection is low and maternal treatment before delivery minimises the presence of virus at delivery. Aciclovir can be given prophylactically to the baby during the at-risk period, but its efficacy is unproven.

Hypoglycaemia

Hypoglycaemia is particularly likely in the first 24 h of life in babies with intrauterine growth restriction, who are preterm, born to mothers with diabetes mellitus, are large-for-dates, hypothermic, polycythaemic or ill for any reason. Growth-restricted and preterm infants have poor glycogen stores, whereas the infants of a diabetic mother have sufficient glycogen stores, but hyperplasia of the islet cells in the pancreas causes high insulin levels. Symptoms are jitteriness, irritability, apnoea, lethargy, drowsiness and seizures.

There is no agreed definition of hypoglycaemia in the newborn. Many babies tolerate low blood glucose levels in the first few days of life, as they are able to utilise lactate and ketones as energy stores. Recent evidence suggests that blood glucose levels above 2.6 mmol/L are desirable for optimal neurodevelopmental outcome, although during the first 24 h after birth many asymptomatic infants transiently have blood glucose levels below this level. There is good evidence that prolonged, symptomatic hypoglycaemia can cause permanent neurological disability.

Hypoglycaemia can usually be prevented by early and frequent milk feeding. In infants at increased risk of hypoglycaemia, blood glucose is regularly monitored at the bedside. If an asymptomatic infant has two low glucose values (i.e. below 2.6 mmol/L) in spite of adequate feeding or one very low value (<1.6 mmol/L) or becomes symptomatic, glucose is given by intravenous infusion aiming to maintain the glucose >2.6 mmol/L. The concentration of the intravenous dextrose may need to be increased from 10% to 15% or even 20%. Abnormal blood glucose results should be confirmed in the laboratory. High-concentration intravenous infusions of glucose should be given via a central venous catheter to avoid extravasation into the tissues, which may cause skin necrosis and reactive hypoglycaemia. If there is difficulty or delay in starting the infusion, or a satisfactory response is not achieved, glucagon or hydrocortisone can be given.

Neonatal seizures

Many babies startle or have tremors when stimulated or make strange jerks during active sleep. Seizures, on the other hand, are unstimulated. Typically, there are repetitive, rhythmic (clonic) movements of the limbs which persist despite restraint and are often accompanied by eye movements and changes in respiration. Many neonatal units now use continuous single channel EEG (amplified integrated EEG, also called a cerebral function monitor) to be able to confirm changes in electrical discharges in the brain. The causes of seizures are listed in Box 10.3.

Whenever seizures are observed, hypoglycaemia and meningitis need to be excluded or treated urgently. A cerebral ultrasound is performed to identify haemorrhage or cerebral malformation. Identification of some cerebral ischaemic lesions or cerebral malformations will require MRI scans of the brain. Treatment is directed at the cause, whenever possible. Ongoing or repeated seizures are treated with an anticonvulsant, although their efficacy in suppressing seizures is much poorer than in older children. The prognosis depends on the underlying cause.

Cerebral infarction (neonatal stroke)

Infarction in the territory of the middle cerebral artery may present with seizures at 12–48 h in a term infant. The seizures may be focal or generalised. In contrast to infants with hypoxic-ischaemic encephalopathy, there are no other abnormal clinical features. The diagnosis is confirmed by MRI (Fig. 10.23). The mechanism is thought to be thrombotic, either thromboembolism from placental vessels or sometimes secondary to inherited thrombophilia. In spite of pronounced abnormalities on the MRI scans, the prognosis is relatively good, with only 20% having hemiparesis or epilepsy presenting later in infancy or early childhood.

Craniofacial disorders

Cleft lip and palate

A cleft lip (Fig. 10.24a) may be unilateral or bilateral. It results from failure of fusion of the frontonasal and maxillary processes. In bilateral cases the premaxilla is anteverted. Cleft palate results from failure of fusion of the palatine processes and the nasal septum. Cleft lip and palate affect about 0.8 per 1000 babies. Most are inherited polygenically, but they may be part of a syndrome of multiple abnormalities, e.g. chromosomal disorders. Some are associated with maternal anticonvulsant therapy. They may be detected on antenatal ultrasound scanning.

Surgical repair of the lip (Fig. 10.24b) may be performed within the first week of life for cosmetic reasons, although some surgeons feel that better results are obtained if surgery is delayed. The palate is usually repaired at several months of age. A cleft palate may make feeding more difficult, but some affected infants can still be breast-fed successfully. In bottle-fed babies, if milk is observed to enter the nose and cause coughing and choking, special teats and feeding devices may be helpful. Orthodontic advice and a dental prosthesis may help with feeding. Secretory otitis media is relatively common and should be sought on follow-up. Infants are also prone to acute otitis media. Adenoidectomy is best avoided, as the resultant gap between the abnormal palate and nasopharynx will exacerbate feeding problems and the nasal quality of speech. A multidisciplinary team approach is required, involving plastic and ENT surgeons, paediatrician, orthodontist, audiologist and speech therapist. Parent support groups can provide valuable support and advice for families (Cleft Lip and Palate Association, CLAPA).

Pierre Robin sequence

The Pierre Robin sequence is an association of micrognathia (Fig. 10.25), posterior displacement of the tongue (glossoptosis) and midline cleft of the soft palate. There may be difficulty feeding and, as the tongue falls back, there is obstruction to the upper airways which may result in cyanotic episodes. The infant is at risk of failure to thrive during the first few months. If there is upper airways obstruction, the infant may need to lie prone, allowing the tongue and small mandible to fall forward. Persistent obstruction can be treated using a nasopharyngeal airway. Eventually the mandible grows and these problems resolve. The cleft palate can then be repaired.

Gastrointestinal disorders

Oesophageal atresia

Oesophageal atresia is usually associated with a tracheo-oesophageal fistula (Fig. 10.26). It occurs in 1 in 3500 live births and is associated with polyhydramnios during pregnancy. If suspected, a wide-calibre feeding tube is passed and checked by X-ray to see if it reaches the stomach. If not diagnosed at birth, clinical presentation is with persistent salivation and drooling from the mouth after birth. If the diagnosis is not made at this stage, the infant will cough and choke when fed, and have cyanotic episodes. There may be aspiration into the lungs of saliva (or milk) from the upper airways and acid secretions from the stomach. Almost half of the babies have other congenital malformations, e.g. as part of the VACTERL association (Vertebral, Anorectal, Cardiac, Tracheo-oEsophageal, Renal and Radial Limb anomalies). Continuous suction is applied to a tube passed into the oesophageal pouch to reduce aspiration of saliva and secretions pending transfer to a neonatal surgical unit.

Small bowel obstruction

This may be recognised antenatally on ultrasound scanning. Otherwise, small bowel obstruction presents with persistent vomiting, which is bile-stained unless the obstruction is above the ampulla of Vater. Meconium may initially be passed, but subsequently its passage is usually delayed or absent. Abdominal distension becomes increasingly prominent the more distal the bowel obstruction. High lesions will present soon after birth, but lower obstruction may not present for some days.

Small bowel obstruction may be caused by:

The diagnosis is made on clinical features and abdominal X-ray showing intestinal obstruction. Atresia or stenosis of the bowel and malrotation are treated surgically, after correction of fluid and electrolyte depletion. A meconium plug will usually pass spontaneously. Meconium ileus may be dislodged using Gastrografin contrast medium.

Exomphalos/gastroschisis

These lesions are often diagnosed antenatally (see Ch. 9). In exomphalos (also called omphalocele), the abdominal contents protrude through the umbilical ring, covered with a transparent sac formed by the amniotic membrane and peritoneum (Fig. 10.28). It is often associated with other major congenital abnormalities. In gastroschisis, the bowel protrudes through a defect in the anterior abdominal wall, adjacent to the umbilicus, and there is no covering sac (see Fig. 9.2). It is not associated with other congenital abnormalities.

Gastroschisis carries a much greater risk of dehydration and protein loss, so the abdomen of affected infants should be wrapped in several layers of clingfilm to minimise fluid and heat loss. A nasogastric tube is passed and aspirated frequently and an intravenous infusion of dextrose established. Colloid support is often required to replace protein loss. Many lesions can be repaired by primary closure of the abdomen. With large lesions, the intestine is enclosed in a silastic sac sutured to the edges of the abdominal wall and the contents gradually returned into the peritoneal cavity.